356 related articles for article (PubMed ID: 19460370)
21. ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.
Salvatore MF
J Neurochem; 2014 May; 129(3):548-58. PubMed ID: 24410633
[TBL] [Abstract][Full Text] [Related]
22. Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging Rats.
Arnold JC; Salvatore MF
ACS Chem Neurosci; 2016 Feb; 7(2):227-39. PubMed ID: 26599339
[TBL] [Abstract][Full Text] [Related]
23. Effects of the unilateral striatal lesion on neurotransmitter markers in the contralateral striatum and both substantia nigrae of the rat.
Masuo Y; Kanazawa I
Neuroscience; 1988 Dec; 27(3):827-36. PubMed ID: 2908058
[TBL] [Abstract][Full Text] [Related]
24. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
25. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
[TBL] [Abstract][Full Text] [Related]
27. Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons.
Zhou X; Pace J; Filichia E; Lv T; Davis B; Hoffer B; Selman W; Luo Y
Exp Neurol; 2016 Sep; 283(Pt A):235-45. PubMed ID: 27317298
[TBL] [Abstract][Full Text] [Related]
28. Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system.
Rosenblad C; Georgievska B; Kirik D
Eur J Neurosci; 2003 Jan; 17(2):260-70. PubMed ID: 12542662
[TBL] [Abstract][Full Text] [Related]
29. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
Kirik D; Rosenblad C; Björklund A
Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
[TBL] [Abstract][Full Text] [Related]
30. GDNF is important for striatal organization and maintenance of dopamine neurons grown in the presence of the striatum.
Chermenina M; Schouten P; Nevalainen N; Johansson F; Orädd G; Strömberg I
Neuroscience; 2014 Jun; 270():1-11. PubMed ID: 24726488
[TBL] [Abstract][Full Text] [Related]
31. Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.
Smith AD; Antion M; Zigmond MJ; Austin MC
Brain Res Mol Brain Res; 2003 Oct; 117(2):129-38. PubMed ID: 14559146
[TBL] [Abstract][Full Text] [Related]
32. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
Kobayashi S; Ogren SO; Hoffer BJ; Olson L
Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
[TBL] [Abstract][Full Text] [Related]
33. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.
Mark KA; Soghomonian JJ; Yamamoto BK
J Neurosci; 2004 Dec; 24(50):11449-56. PubMed ID: 15601951
[TBL] [Abstract][Full Text] [Related]
34. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
35. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat.
Kozlowski DA; Miljan EA; Bremer EG; Harrod CG; Gerin C; Connor B; George D; Larson B; Bohn MC
Brain Res; 2004 Aug; 1016(2):170-81. PubMed ID: 15246853
[TBL] [Abstract][Full Text] [Related]
37. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.
Ai Y; Markesbery W; Zhang Z; Grondin R; Elseberry D; Gerhardt GA; Gash DM
J Comp Neurol; 2003 Jun; 461(2):250-61. PubMed ID: 12724841
[TBL] [Abstract][Full Text] [Related]
38. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
39. Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism.
Brown AM; Deutch AY; Colbran RJ
Eur J Neurosci; 2005 Jul; 22(1):247-56. PubMed ID: 16029214
[TBL] [Abstract][Full Text] [Related]
40. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
Cass WA; Peters LE
Neurochem Int; 2010 Nov; 57(5):540-6. PubMed ID: 20615442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]